13F reference period
Q2 2026
Security Snapshot
Annovis Bio, Inc. - Common Stock, $0.0001 par value per share (ANVS) Institutional Ownership
CUSIP: 03615A108
13F Institutional Holders and Ownership History from Q1 2020 to Q3 2026
Institutions Reporting
61
Shares (Excl. Options)
10.85M
Full value: 10,852,686 · shares · 30 Jun 2026Price
$1.86
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- ANVS on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 10,852,686
- Total 13F value
- $20,187,942
- Portfolio coverage rank
- 0%
- Share change
- +6,130,556
- Value change
- +$11,325,255
- Number of holders
- 61
- Shares outstanding
- 44,920,581
- SEC-reported price per share
- $1.27
- Insider filing price
- $1.27
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ANVS - Annovis Bio, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 03615A108.
- 61 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 55 to 61 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$10.53M
Full value: $10,526,305 · USD · 31 Mar 2026.$20.19M
Full value: $20,187,942 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 61 institutions filings for Q2 2026.
Security key
03615A108
13F reference period
Q2 2026
13F holders
61
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
ANVS full holder history
Annovis Bio, Inc. SEC filings
Annovis Bio, Inc. company facts
Annovis Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03615A108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ANVS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6.1% | $5,467,889 | 2,775,578 | Highbridge Capital Management, LLC | 30 Jun 2026 | |||
| Empery Asset Management, LP | 5% | -11% | $2,846,752 | -$203,123 | 2,241,537 | -6.7% | Empery Asset Management, LP | 30 Sep 2026 |
| CVI Investments, Inc. | 4.9% | -4% | $1,470,000 | 1,000,000 | 0% | CVI Investments, Inc. | 31 Mar 2025 |
As of 30 Jun 2026,
61
institutional investors reported holding
shares of
Annovis Bio, Inc. - Common Stock, $0.0001 par value per share (ANVS).
This represents
24%
of the company’s total
outstanding shares.
10.85M
Full value: 10,852,686 · shares · 30 Jun 202644.92M
Full value: 44,920,581 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 5.3% | 2,401,476 | 5.2% | $4,466,745 | |
| MARSHALL WACE, LLP | 4.1% | 1,842,339 | +55% | 0% | $3,426,750 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 1,647,322 | +89% | 0% | $3,064,019 |
| TUDOR INVESTMENT CORP ET AL | 3% | 1,357,134 | 0.01% | $2,524,269 | |
| RENAISSANCE TECHNOLOGIES LLC | 2.2% | 1,002,200 | +188% | 0% | $1,864,092 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 579,571 | -7.7% | 0% | $1,078,002 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.63% | 283,817 | +15% | 0% | $528,134 |
| BlackRock, Inc. | 0.56% | 249,856 | +79% | 0% | $464,732 |
| CITADEL ADVISORS LLC | 0.54% | 243,682 | 0% | $453,249 | |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 177,530 | +34% | 0% | $330,206 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.33% | 146,804 | -33% | 0% | $273,056 |
| Quadrature Capital Ltd | 0.2% | 90,884 | 0% | $169,044 | |
| STATE STREET CORP | 0.17% | 77,735 | 0% | 0% | $144,587 |
| NORTHERN TRUST CORP | 0.15% | 68,070 | -52% | 0% | $126,610 |
| First National Trust Co | 0.13% | 60,000 | +50% | 0% | $111,600 |
| Sherry Group, Inc. | 0.13% | 57,270 | 0% | 0.1% | $106,523 |
| GSA CAPITAL PARTNERS LLP | 0.11% | 49,904 | +9.9% | 0.01% | $93,000 |
| Greenwich Wealth Management LLC | 0.11% | 48,400 | +3% | 0% | $90,000 |
| Headlands Technologies LLC | 0.11% | 48,071 | 0.01% | $89,412 | |
| Wescott Financial Advisory Group, LLC | 0.09% | 41,607 | 0% | 0.01% | $77,389 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.08% | 37,677 | 0% | 0% | $70,079 |
| WELLS FARGO & COMPANY/MN | 0.07% | 30,307 | +112% | 0% | $56,372 |
| Dakota Wealth Management | 0.06% | 29,000 | +12% | 0% | $53,940 |
| CWA Asset Management Group, LLC | 0.06% | 28,001 | +65% | 0% | $52,081 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | 23,463 | 0% | $43,641 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
27
Headline period
Q2 2026
Rows shown
1-25 of 27
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 146,605 | $186,188 | +$33 | $1.27 | 11 |
| 2026 Q2 | 10,852,686 | $20,187,942 | +$11,325,255 | $1.86 | 61 |
| 2026 Q1 | 4,722,030 | $10,526,305 | +$161,247 | $2.23 | 55 |
| 2025 Q4 | 4,237,986 | $14,662,646 | +$8,024,097 | $3.46 | 52 |
| 2025 Q3 | 2,024,516 | $4,189,707 | +$428,194 | $2.07 | 42 |
| 2025 Q2 | 1,811,877 | $3,929,691 | -$326,377 | $2.17 | 42 |
| 2025 Q1 | 2,086,860 | $3,130,127 | -$507,485 | $1.50 | 43 |
| 2024 Q4 | 1,575,712 | $7,926,263 | +$1,704,856 | $5.03 | 40 |
| 2024 Q3 | 1,179,026 | $9,503,457 | +$1,923,073 | $8.06 | 35 |
| 2024 Q2 | 984,218 | $5,669,358 | -$2,073,596 | $5.76 | 29 |
| 2024 Q1 | 1,190,821 | $14,170,568 | -$404,974 | $11.90 | 29 |
| 2023 Q4 | 1,204,452 | $22,522,950 | +$2,419,829 | $18.70 | 35 |
| 2023 Q3 | 1,111,889 | $10,551,231 | -$1,631,804 | $9.49 | 28 |
| 2023 Q2 | 1,278,556 | $18,270,029 | +$7,489,629 | $14.29 | 27 |
| 2023 Q1 | 752,202 | $11,588,203 | +$250,861 | $15.41 | 22 |
| 2022 Q4 | 736,307 | $9,887,632 | +$230,554 | $13.43 | 21 |
| 2022 Q3 | 718,857 | $9,847,000 | -$399,073 | $13.70 | 20 |
| 2022 Q2 | 770,387 | $8,735,000 | -$1,477,097 | $11.33 | 24 |
| 2022 Q1 | 888,924 | $11,867,000 | -$3,780,511 | $13.35 | 22 |
| 2021 Q4 | 1,115,969 | $19,619,000 | -$2,600,801 | $17.58 | 29 |
| 2021 Q3 | 1,140,634 | $36,227,000 | -$24,730,573 | $31.74 | 36 |
| 2021 Q2 | 1,272,982 | $108,947,000 | +$39,294,497 | $85.59 | 56 |
| 2021 Q1 | 834,363 | $23,108,000 | +$2,874,108 | $27.90 | 29 |
| 2020 Q4 | 759,911 | $5,730,000 | +$93,763 | $7.55 | 12 |
| 2020 Q3 | 315,551 | $1,518,000 | +$388,364 | $4.81 | 11 |